LifeMD
LFMD
45 hedge funds and large institutions have $19.3M invested in LifeMD in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 10 closing their positions.
65% more call options, than puts
Call options by funds: $791K | Put options by funds: $478K
7% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 15
2.69% less ownership
Funds ownership: 19.51% → 16.82% (-2.7%)
15% less funds holding
Funds holding: 53 → 45 (-8)
17% less capital invested
Capital invested by funds: $23.1M → $19.3M (-$3.83M)
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$859K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$522K |
| 3 |
WANY
Wealthspire Advisors (New York)
New York
|
+$222K |
| 4 |
BRF
B. Riley Financial
Los Angeles,
California
|
+$212K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$136K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
-$803K |
| 2 |
Two Sigma Investments
New York
|
-$769K |
| 3 |
Renaissance Technologies
New York
|
-$713K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$496K |
| 5 |
Millennium Management
New York
|
-$343K |
LFMD Hedge Fund Activity: Q1 2022 in Review
45 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q1 2022, worth a combined $19.3M — down 17% from $23.1M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of LFMD and 2 opened new positions — a net loss of 8 holders — while 15 trimmed existing stakes and 14 added.
The largest buyer was Granahan Investment Management, adding an estimated $859K. The largest seller was Two Sigma Advisers, cutting an estimated $803K.
- 45 institutional investors held LifeMD (LFMD) as of Q1 2022, down from 53 in Q4 2021.
- Funds reported $19.3M of LifeMD stock for Q1 2022, down 17% quarter-over-quarter.
- 2 funds opened new LifeMD positions in Q1 2022 and 10 closed out, a net change of -8 holders.
- The largest LifeMD buyer in Q1 2022 was Granahan Investment Management, an estimated $859K added.
- The largest LifeMD seller in Q1 2022 was Two Sigma Advisers, an estimated $803K sold.
Based on aggregated 13F filings for Q1 2022.